Wolfe Med Tools: LAUNCH FEEDBACK…“the bottom signal we’ve all been waiting for” -device investor

Research evidence excerpt

Wolfe Med Tools: LAUNCH FEEDBACK…“the bottom signal we’ve all been waiting for” -device investor

Life Science Tools & Diagnostics

Bioprocessing and Drug Packaging - Market Overweight

Life Science Tools (Diversified) - Market Weight

Specialty Diagnostics - Market Overweight

Wolfe Med Tools: LAUNCH FEEDBACK…“the bottom June 5, 2026

signal we’ve all been waiting for” -device investor

The Wolfe Byte

ICYMI: Wolfe Med Tech -> Wolfe Med Tools with launches on 18 names this week

●Wolfe Med Tools: Test Test Test – This Mike On? Assume Coverage of 12 Tools Stocks

●Wolfe Med Tools: Your New Inbox Cancer – Assume Coverage of 6 Specialty Diagnostics Stocks

Anonymous investor feedback ensues – disclaimer first: We do not intend to initiate a recurring publication of copy-

paste-share direct quotes ahead – hasn’t been part of the library in devices, don’t intend to do that in Tools/Dx.

HOWEVER…Tools/Dx transition a major 1x event – launches precipitate a range of feedback both small & big picture.

Hence our writing here on ‘what we heard’. Did this make us think we started completely offsides/delusional? No (phew).

But there is always a debate/squint/angle/poke…duh! Enjoy. And thank you to those dear readers that contributed :)

Simply wanted to let you know I voted for Mike in II/Extel. I voted for him in Medical Supplies/Devices but thought the

recent Tools launch was fantastic work.

Can you send the backup Excel for the charts in your initiation pack? I thought the returns analysis, constant-dollar

organic revenue growth, etc. were all super interesting.

Huh? Didn’t see this coming

I will say from a secular picture: tools > devices. But tools end markets are so opaque.

Hear you and mostly agree….EV/EBITDA…is the right metric for this group (e.g., DHR pretends to pay taxes on income